171 results on '"KAY, Sigi"'
Search Results
2. Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
3. The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive Microscopy
4. P651: REAL-WORLD EFFECTIVENESS OF VENETOCLAX-BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY
5. Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
6. The Generation of Chromosomal Alterations During Mitosis in Primary Central Nervous System Diffuse Large B-cell Lymphoma
7. Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations
8. Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival
9. Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study
10. Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis
11. Comprehensive Morphological Assessment of Cord Blood: Normal Values and the Prevalence of Morphologically Aberrant Leukocytes
12. Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study
13. Increased CD39 expression on CD4+ T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia
14. Toxicity and Efficacy of CAR-T in Patients with DLBCL Above the Age of 70 Years Compare to Younger Patients – a Matched Control Multi-Center Cohort Study
15. Differential diagnosis of malignant mononuclear cells in the cerebrospinal fluid: Merkel carcinoma cells
16. Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
17. INTEGRATION OF AUTOMATED MORPHOLOGICAL FEATURES RESOLVES A DISTINCT GROUP OF ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIAS WITH CHROMOSOMAL ABERRATIONS: 513
18. Comprehensive Morphological Assessment of Cord Blood: Normal Values and the Prevalence of Morphologically Aberrant Leukocytes.
19. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood
20. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6
21. Front Cover
22. Pathogenic heparin‐induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry
23. Pathogenic Heparin Induced Thrombocytopenia and Thrombosis (HIT) Antibodies Determined By Simple Rapid Functional Flow Cytometry
24. 51 - Toxicity and Efficacy of CAR-T in Patients with DLBCL Above the Age of 70 Years Compare to Younger Patients – a Matched Control Multi-Center Cohort Study
25. Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
26. Lymphocyte Activation Gene 3-a Novel Therapeutic Target in Chronic Lymphocytic Leukemia
27. Easily Performed Functional Flow Cytometry Assay for Heparin-Induced Thrombocytopenia and Thrombosis (HIT): Correlation with Clinical Presentation, Immunoassay and Serotonin-Release Assay
28. Differential diagnosis of malignant mononuclear cells in the cerebrospinal fluid: Merkel carcinoma cells.
29. Flow Cytometry-based Detection of B-cell Lymphoproliferative Disorders in Patients with Mycosis Fungoides.
30. Leukemia Cell Xenograft in Ovo Enables Real-Time Testing of Response to Therapy
31. Sensitive and Specific Functional Flow Cytometry Assay for Rapid Diagnosis of Heparin Induced Thrombocytopenia and Thrombosis (HIT)
32. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia
33. New Xenograft Method For Studying Leukemia and Drug Response In Turkey Embryos
34. Heparin-Induced Thrombocytopenia: A Rapid, Reliable and Practical, Functional Flow-Cytometric Assay
35. Absolute Monocyte Count Trichotomizes Chronic Lymphocytic Leukemia Into High Risk Patients With Immune Dysregulation, Disease Progression and Poor Survival
36. Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells
37. CD84 is a survival receptor for chronic lymphocytic leukemia cells (P2044)
38. Divergence in CD19-Mediated Signaling Unfolds Intraclonal Diversity in Chronic Lymphocytic Leukemia, Which Correlates with Disease Progression
39. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
40. Divergence in CD19-Mediated Signaling Unfolds Intra-Clonal Diversity in Chronic Lymphocytic Leukemia Which Correlates with Disease Progression
41. The Role of the IAP Livin in Megakaryocytes Differentiation and Thrombopoiesis
42. Complete Spontaneous Regression of Chronic Lymphocytic Leukemia
43. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia
44. Increased CD39 Expression on CD4+ T-Lymphocytes Has Clinical and Prognostic Significance in Chronic Lymphocytic Leukemia,
45. 2.7 Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression in CLL
46. A New Xenograft Model for Studying Multiple Myeloma and Drug Response
47. Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression In Chronic Lymphocytic Leukemia (CLL)
48. Unexpected detection of monoclonal B‐cell lymphocytosis in a HLA‐matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcome
49. A New In Vivo Platform for Studying the Growth of Hematopoietic Cancer Initiating Blood Cells and Response to Therapy.
50. Mimicking the Hematopoietic Niche Microenvironment Provides a Novel Strategy for Expansion of Hematopoietic and Megakaryocyte-Progenitor Cells from Cord Blood
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.